- For the University
- For external organisations
- Contact us
Our door is always open for an exploratory chat about how you might develop your ideas commercially or use your expertise.
In the interests of reducing spam, we have removed individual email addresses, but you are welcome to contact one of us directly by using firstname.lastname@example.org.
For other enquiries, please complete our general enquiry form.
Cambridge Enterprise’s role is to support University staff and students in creating world-class societal benefit through commercialisation of their world-leading research and scholarship. Tony’s aspiration for Cambridge Enterprise is to 'have fun and make a difference' supporting the full breadth of opportunities across the campus, from archaeology to zoology, with an ambition worthy of a university of Cambridge’s international standing.
This strategy has resulted in tremendous growth for Cambridge Enterprise; since 2011, its venture funding capacity has grown by 730%, the number of spin-outs created has gone up by 250%, and its consultancy support service has increased by 90%. Today, Cambridge Enterprise is one of the most successful offices internationally. Compared to its international peers, it generates more licences per £/$ of research funding and at the lowest cost per licence, while Cambridge University spin-outs have raised the largest amount of investment in total over the past five years.
Starting in academia and before coming back into academia, Tony had a long history as a successful technology entrepreneur. The companies he has founded include Summit Technology, the pioneer of laser refractive surgery, which was acquired by Nestle Alcon in 2000 for $893 million; publicly-quoted Cambridge technology consultancy Sagentia plc; and Diomed Inc, a pioneer of surgical diode lasers which was listed in the US in 2002 before being acquired by a Angiodynamics Inc in 2008.
Tony is a Fellow of the Institute of Physics and a Member of the Institute of Directors. He joined Cambridge Enterprise as CEO in December 2011.
Paul is Deputy Director of Cambridge Enterprise. He is responsible for implementing a five year strategy that aims to enhance our customer service so that we can help more academics, researchers, companies and investors to create a positive impact on society. A cornerstone of the strategy is the introduction of a new IT system that will enable customers to access data as well as driving greater efficiency within the business.
Paul was previously Head of Consultancy Services for six years, during which period he doubled the team’s turnover. He is a Board member and Director of three University of Cambridge subsidiary companies: Cambridge Enterprise Limited, Cambridge University Technical Services (CUTS) Limited and Institute for Manufacturing Education and Consultancy Services Limited.
Paul has considerable experience of technology transfer in both the biotech and medtech sectors. He was previously Head of Business Development at Health Enterprise East, where he was instrumental in building a successful technology transfer and consultancy organisation for the NHS. Before that, he was a Technology Manager at Cambridge Enterprise for more than three years and led its Life Sciences team. Paul also spent five years as a Senior Scientist with a Cambridge biotech company that had spun out of the University, helping it to develop its medtech business.
Paul has a degree in Biochemistry and a PhD in Chemistry from Manchester. After his PhD, he became a post-doctoral researcher for the Medical Research Council and then later for the University of Cambridge.
Paul first joined Cambridge Enterprise in 2001 and returned after he completed his time with Health Enterprise East in 2009.
Boris is responsible for the Business Support team and for information analysis and reporting.
He oversees project developments and the IP portfolio management system, as well as related processes and management information reporting.
Prior to his current post, Boris held several roles at Cambridge Enterprise including Business Support Manager and Senior Technology Associate in the Life Sciences team.
Before joining Cambridge Enterprise, Boris worked as a research associate for an international executive search consultancy providing senior manager and executive recruitment services to the life science and healthcare industries.
Boris has an MSc in Biology from the University of Montpellier (France) and Level 5 Award in Management from the Institute of Leadership and Management.
Boris joined the Technology Transfer Office of the University (which became Cambridge Enterprise in 2006) in September 2003.
As Head of Seed Funds at Cambridge Enterprise, Anne has overseen strong growth in our investment activities, with Seed Funds investing over £5 million each year in young companies.
Recent highlights include the purchase of Cambridge CMOS Sensors by ams, and the sale of Quethera to Astellas Pharma. Anne has also served on many boards including those of Cambridge CMOS Sensors, Aqdot, Cambridge Touch Technologies, Psyomics, MorphoenIX and Quethera. She was a founding member of Praxis Auril, which supports Knowledge Exchange Commercialisation in the UK.
Anne’s early career includes experience in technology transfer at Imperial College Innovations Limited, in pharmaceutical development at Evans Medical, and in pharmaceutical product training at Information Transfer.
Anne holds a BSc in Medical Microbiology and a PhD in Immunology.
Anne joined the technology transfer team at the University of Cambridge in 2001, and has been involved with Cambridge Enterprise since its foundation in 2006, including as Interim Director just prior to this. She joined the Seed Funds team in 2008 and was appointed Head of Seed Funds in 2011.
As Head of International Relations & Outreach, Caroline helps other universities and governments to learn from Cambridge Enterprise’s experience and expertise to develop and enhance their own commercialisation activities.
By helping to improve technology transfer and commercialisation skills in other countries, we seek to enable other universities to deliver effective research impact and solutions to world issues. In this role, Caroline oversees our International Open Programme as well as working with a number of talented and experienced Associates to deliver bespoke programmes and projects internationally.
Caroline joins from her previous role as CEO for Allia Future Business Centres Ltd where she established an initial innovation and incubation centre for social ventures and ‘tech for good’ companies and built out a network of four centres operating across Cambridge, London and Peterborough. Caroline has spent over 20 years working with entrepreneurship and innovation in and around Cambridge and is well networked in the Cambridge ecosystem. She brings this, as well as previous experience working in a research, development and commercialisation department of a UK University, to ensure that international partners benefit from the richest experience of engagement.
Caroline is a Fellow of the RSA.
Caroline joined Cambridge Enterprise in March 2020.
As Head of Finance and Accounting, Mark is responsible for the accounting function of Cambridge Enterprise, including effective recording, accounting and reporting, as well as meeting annual audit and other compliance obligations.
In addition to traditional finance and accounting duties, the Finance Team is responsible for the accurate and timely distribution of income received from commercialisation activities to parties including academics, departments, research funders and third parties.
Mark has been instrumental in automating the quarterly close process and implementing new accounting systems to better serve the business units and support functions of the organisation. Mark is the Assistant Company Secretary for the organisation, carrying out company secretarial duties on behalf of the Registrary of the University of Cambridge, and is also the Cambridge representative LLP Committee Member for Apollo Therapeutics LLP.
Mark has held a variety of accounting, reporting and financial compliance roles for UK, US and European companies of varying sizes, in head office as well as subsidiary environments. Mark has over 20 years’ accounting experience, working in public practice and industry for a variety of companies including capital equipment manufacturing, healthcare, agrochemical and dot com.
Mark is a Fellow Member of the Association of Chartered Certified Accountants (FCCA) and graduated with a BSc Hons in Business Information Systems.
Mark joined Cambridge Enterprise in 2009.
Christian is leading the Marketing and Communications team in developing and implementing a strategic, integrated approach to serving Cambridge Enterprise’s customers and expanding its markets.
Christian’s focus is on better understanding the expectations of the University’s academics and researchers as the starting point for devising a more relevant and effective marketing mix. At the same time, Christian and the team are working constantly to showcase the world-class technologies and innovations available through Cambridge Enterprise, and to illustrate the wider benefits that commercialisation provides for society and the economy.
Christian has previously worked for a variety of consumer and business-facing organisations including Imperial War Museums, Rail Delivery Group, Avis and Prudential.
A graduate of the University of Southampton, Christian is a member of the Chartered Institute of Marketing and holds the Institute’s Postgraduate Diploma in Marketing.
Christian joined Cambridge Enterprise in 2017.
As Head of Human Resources (HR), Ruth guides, manages and provides strategy on the people function of Cambridge Enterprise.
In this role, Ruth has been developing and implementing HR best practice in areas such as employee engagement and communication, attracting and managing talent, employee reward, and employee wellbeing. This progress is reflected in our Gold accreditation as one of the Best Employers in the Eastern Region for 2018.
Ruth values the flexible and agile working environment at Cambridge Enterprise, as well as the inclusive and engaged culture.
Ruth has over 20 years’ HR experience, working across various sectors including not-for-profit (Cambridge-based housing associations CHS Group and Granta Housing Society), new business (high tech start-up Geneva Technology) and global corporation (Convergys).
Ruth holds Chartered Member status of the CIPD and graduated with a BA Hons in Philosophy and European Literature.
Ruth joined Cambridge Enterprise in 2014.
Marcio leads the Physical Sciences team at Cambridge Enterprise, working to help researchers commercialise technologies from across the whole range of the Schools of Physical Sciences and Technology.
Prior to joining Cambridge Enterprise, Marcio was with Imperial College London in a similar role for close to two years. Before that, Marcio enjoyed working in his own company in the field of scientific instrumentation for high pressure research, from where he exited in 2018, after 16 years. At the time of his exit the company had offices in the UK, US, Belgium and China. Previous to this, he worked for a medical devices company with full new product development and introduction responsibilities.
His scientific background is in physics, with a PhD from Royal Holloway, University of London. He also has an MBA from the University of Surrey and is a Certified Licensing Professional.
Marcio joined Cambridge Enterprise in March 2021.
Iain is Head of Life Sciences at Cambridge Enterprise, responsible for a team that is working across the life sciences sector from human health therapeutics to agritech and research tools. Iain has a PhD in Organic Chemistry (Sydney) and MBA (Cambridge).
The team has spun-out companies including X01 Therapeutics, Apcintex (now a Centessa company), DIOSynVax, NoBACZ Healthcare, Predictimmune Limited, PhoreMost, Z-factor and Cambridge Epigenetix. Iain, with colleagues from partner universities founded Apollo Therapeutics, a £40 million fund in early stage drug development and launched the Ceres Agritech Knowledge Exchange Partnership. Iain also led discussions with GSK in respect of the University of Cambridge-GSK open innovation drug discovery initiative based at the Stevenage Bioscience Catalyst.
Iain joined Cambridge Enterprise in November 2003.
As CTO, Matt’s role involves leading the IT team, working with Cambridge Enterprise strategic project groups to provide expertise, support and advice on their IT requirements, developing the IT strategy, and researching, recommending and project managing new IT technology solutions, thus helping Cambridge Enterprise engage with its customers, streamline business processes, and allow staff to be more effective.
Graduating from Cambridge in Engineering, Matt followed a career in web design and development, then enterprise applications and finally the full IT portfolio, working for many years in the media sector (Emap plc and The Guardian), but more recently a Tennessee software company and Cambridgeshire County Council.
Having also studied IT Leadership at Cranfield University, Matt attained Chartered IT Professional (CITP) status.
Matt joined Cambridge Enterprise in January 2019.
Amanda is Head of Consultancy Services, a fast-growing service dedicated to generating both societal and economic impact from academic research by facilitating consultancy between University academics from across all disciplines within the University and external organisations.
The Consultancy Services team has supported almost 400 consultancy projects this past year of which many arose from Arts, Humanities or Social Science disciplines. In 2017-18, Amanda’s team saw a 63% increase in the number of new consultants with deals signed for 165 academics and 234 clients in that period.
Amanda periodically delivers training to technology transfer professionals for PraxisAuril, the Association of University Technology Managers (AUTM) and the European Association for Technology Transfer Professionals (ASTP), and is on the Board of Directors for ASTP as VP for Professional Development.
Amanda previously worked for the University of Nottingham’s School of Pharmacy, where she ran a newly created interdisciplinary Doctoral Training Centre. As Project Manager, she co-ordinated the PhD programme and brought together academics and industry to generate collaborative research projects in targeted therapeutics as well as running a government-funded project to develop researchers’ transferable skills. She has also worked for the Food Standards Agency in scientific policy and for Isis Research (now known as Synovate Healthcare) where she was responsible for planning, implementing and analysing large international studies on HIV therapy for the pharmaceutical industry.
Amanda has a PhD in HIV research from the MRC-Laboratory of Molecular Biology at the University of Cambridge.
Amanda joined Cambridge Enterprise as Consultancy Associate in January 2008 and became Head of Consultancy in February 2015.